News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Paragon and Passage Bio enter a collaboration agreement to develop a dedicated manufacturing suite at the former’s Maryland facility, as the latter’s gene therapy candidates enter the clinic.
Erytech entered an agreement with SQZ to advance RBC-based therapeutics for immune modulation using the latter’s platform.
Grifols builds its first plant in Northern Africa for Morocco-based Soludia Maghreb, which will be used in the production of intravenous solutions bags.